175 related articles for article (PubMed ID: 7007685)
21. Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.
Sullivan JM; Ginsburg BA; Ratts TE; Johnson JG; Barton BR; Kraus DH; McKinstry DN; Muirhead EE
Hypertension; 1979; 1(4):397-401. PubMed ID: 232084
[TBL] [Abstract][Full Text] [Related]
22. Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome.
Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI; Davies DL
Am J Cardiol; 1982 Apr; 49(6):1460-6. PubMed ID: 7041585
[TBL] [Abstract][Full Text] [Related]
23. Long-term efficacy of captopril in renovascular and essential hypertension.
Case DB; Atlas SA; Marion RM; Laragh JH
Am J Cardiol; 1982 Apr; 49(6):1440-6. PubMed ID: 6803561
[TBL] [Abstract][Full Text] [Related]
24. [Effect of captopril on renal vein plasma renin ratio--diagnosis and predicting response to surgery in renovascular hypertension].
Takata M; Sugimoto T; Mikawa M; Yoshida K; Iuchi K; Iida H; Mizumura Y; Nakada T; Kawahara Y
Nihon Jinzo Gakkai Shi; 1983 Aug; 25(8):1017-26. PubMed ID: 6366302
[No Abstract] [Full Text] [Related]
25. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
[TBL] [Abstract][Full Text] [Related]
26. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
27. Screening for congenital renovascular hypoplasia and renal artery stenosis by acute converting enzyme inhibition.
Cottone S; Mercadante G; Contorno A; Giuntini G; Mangano MT; Rabiolo A; Cerasola G
Nephron; 1993; 63(1):54-7. PubMed ID: 8446252
[TBL] [Abstract][Full Text] [Related]
28. The captopril test for identifying renovascular disease in hypertensive patients.
Muller FB; Sealey JE; Case DB; Atlas SA; Pickering TG; Pecker MS; Preibisz JJ; Laragh JH
Am J Med; 1986 Apr; 80(4):633-44. PubMed ID: 3515933
[TBL] [Abstract][Full Text] [Related]
29. Humoral effects of the oral converting-enzyme inhibitor SQ 14,225 in hypertensive patients in supine and tilted position.
Morganti A; Pickering TG; Lopez-Ovejero J; Laragh JH
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():149s-152s. PubMed ID: 232018
[No Abstract] [Full Text] [Related]
30. Renovascular hypertension with low-to-normal plasma renin: clinical and angiographic features.
Rossi GP; Pavan E; Chiesura-Corona M; Bader M; Paganini G; Cesari M; De Toni R; Feltrin GP; Ganten D; Pessina AC
Clin Sci (Lond); 1997 Nov; 93(5):435-43. PubMed ID: 9486089
[TBL] [Abstract][Full Text] [Related]
31. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
[TBL] [Abstract][Full Text] [Related]
32. Use of captopril in the diagnosis of renal hypertension.
McGrath BP; Matthews PG; Johnston CI
Aust N Z J Med; 1981 Aug; 11(4):359-63. PubMed ID: 7030291
[TBL] [Abstract][Full Text] [Related]
33. Captopril stimulation of differential renins in renovascular hypertension.
Lyons DF; Streck WF; Kem DC; Brown RD; Galloway DC; Williams GR; Chrysant SG; Danisa K; Carollo M
Hypertension; 1983; 5(4):615-22. PubMed ID: 6345367
[TBL] [Abstract][Full Text] [Related]
34. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
[TBL] [Abstract][Full Text] [Related]
35. Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat.
Thurston H; Bing RF; Marks ES; Swales JD
Clin Sci (Lond); 1980 Jan; 58(1):15-20. PubMed ID: 6986225
[TBL] [Abstract][Full Text] [Related]
36. Response to the captopril test is dependent on baseline renin profile.
Gerber LM; Mann SJ; Müller FB; Alderman MH; Pickering TG; Sealey JE; Laragh JH
J Hypertens; 1994 Feb; 12(2):173-8. PubMed ID: 8021469
[TBL] [Abstract][Full Text] [Related]
37. Prospective analysis of strategies for diagnosing renovascular hypertension.
Svetkey LP; Himmelstein SI; Dunnick NR; Wilkinson RH; Bollinger RR; McCann RL; Beytas EM; Klotman PE
Hypertension; 1989 Sep; 14(3):247-57. PubMed ID: 2670763
[TBL] [Abstract][Full Text] [Related]
38. Captopril in diuretic-treated hypertensive patients.
Koffer H; Vlasses PH; Ferguson RK; Weis M; Adler AG
JAMA; 1980 Dec; 244(22):2532-5. PubMed ID: 7001071
[TBL] [Abstract][Full Text] [Related]
39. Use of oral converting enzyme inhibitor, captopril for lateralizing renal venous renin activity.
Rosenthal T; Morag B; Holtzman E; Stern N; Knecht A; Grossman E; Rubinstein Z
Clin Exp Hypertens A; 1983; 5(10):1629-34. PubMed ID: 6365362
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of unilateral renovascular hypertension: comparative effect of intravenous enalaprilat and oral captopril.
Tunny TJ; Klemm SA; Hamlet SM; Gordon RD
J Urol; 1988 Oct; 140(4):713-5. PubMed ID: 2843688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
